PERCEPTIVE ADVISORS LLC Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$1.5T
Holdings
193
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (193 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SRPTSAREPTA THERAPEUTICS INC | 3,395,236 | $208.5B | 13.46% | |
| 2 | NBIXNEUROCRINE BIOSCIENCES INC | 2,476,272 | $125.4B | 8.09% | |
| 3 | AM6AMICUS THERAPEUTICS INC | 14,116,644 | $104.5B | 6.74% | |
| 4 | —TESARO INC | 682,415 | $68.4B | 4.42% | |
| 5 | —RETROPHIN INC | 2,446,482 | $54.8B | 3.53% | |
| 6 | GBTUSDGLOBAL BLOOD THERAPEUTICS INC | 2,334,168 | $53.8B | 3.47% | |
| 7 | —VERSARTIS INC | 4,028,685 | $49.4B | 3.19% | |
| 8 | —NXSTAGE MEDICAL INC | 1,669,703 | $41.7B | 2.69% | |
| 9 | XNCRXENCOR INC | 1,496,229 | $36.6B | 2.37% | |
| 10 | —LA JOLLA PHARMACEUTICAL COMPANY | 1,323,324 | $31.5B | 2.03% | |
| 11 | —LION BIOTECHNOLOGIES INC | 3,567,553 | $29.4B | 1.90% | |
| 12 | WVEWAVE LIFE SCIENCES LTD | 683,448 | $22.2B | 1.43% | |
| 13 | XLRNACCELERON PHARMA INC | 589,890 | $21.3B | 1.38% | |
| 14 | —COLUCID PHARMACEUTICALS INC | 552,030 | $21.1B | 1.36% | |
| 15 | —ACELRX PHARMACEUTICALS INC | 5,408,728 | $21.0B | 1.36% | |
| 16 | —QUOTIENT LTD | 2,671,794 | $20.9B | 1.35% | |
| 17 | —DBV TECHNOLOGIES SA-SPON ADR | 563,268 | $20.5B | 1.32% | |
| 18 | CRBPEURCORBUS PHARMACEUTICALS HOLDINGS | 2,701,023 | $18.3B | 1.18% | |
| 19 | RGNXREGENXBIO INC | 1,282,286 | $18.0B | 1.16% | |
| 20 | —RADIUS HEALTH INC | 313,502 | $17.0B | 1.09% | |
| 21 | —FLAMEL TECHNOLOGIES -SP ADR | 1,363,711 | $16.9B | 1.09% | |
| 22 | —KADMON INC | 2,209,657 | $16.2B | 1.05% | |
| 23 | DC4DEXCOM INC | 178,849 | $15.7B | 1.01% | |
| 24 | AERIEURAERIE PHARMACEUTICALS INC | 406,771 | $15.4B | 0.99% | |
| 25 | ALDXALDEYRA THERAPEUTICS INC | 1,940,458 | $15.2B | 0.98% | |
| 26 | ARDXARDELYX INC | 1,057,257 | $13.7B | 0.88% | |
| 27 | 2L9BLUEPRINT MEDICINES CORP | 460,024 | $13.7B | 0.88% | |
| 28 | —DEPOMED INC | 535,000 | $13.4B | 0.86% | |
| 29 | —ALDER BIOPHARMACEUTICALS INC | 391,280 | $12.8B | 0.83% | |
| 30 | —FOAMIX PHARMACEUTICALS LTD | 1,373,284 | $12.7B | 0.82% | |
| 31 | —CYTOMX THERAPEUTICS, INC | 742,021 | $11.6B | 0.75% | |
| 32 | NERVGBPMINERVA NEUROSCIENCES INC | 810,537 | $11.4B | 0.74% | |
| 33 | —ZYNERBA PHARMACEUTICALS INC | 868,897 | $11.3B | 0.73% | |
| 34 | —DERMIRA INC | 331,610 | $11.2B | 0.72% | |
| 35 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 634,801 | $11.0B | 0.71% | |
| 36 | ACRSACLARIS THERAPEUTICS INC | 430,000 | $11.0B | 0.71% | |
| 37 | EVHEVOLENT HEALTH INC CLASS A | 428,284 | $10.5B | 0.68% | |
| 38 | VAC2USDVBI VACCINES INC | 3,058,433 | $10.5B | 0.68% | |
| 39 | —MYOKARDIA INC | 634,894 | $10.4B | 0.67% | |
| 40 | QUREUNIQURE NV | 1,312,836 | $10.0B | 0.65% | |
| 41 | VRTXVERTEX PHARMACEUTICALS INC | 107,000 | $9.3B | 0.60% | |
| 42 | —ANI PHARMACEUTICALS INC | 7,500,000 | $9.3B | 0.60% | |
| 43 | —CIDARA THERAPEUTICS INC | 773,369 | $8.9B | 0.57% | |
| 44 | —FIVE PRIME THERAPEUTICS INC | 166,509 | $8.7B | 0.56% | |
| 45 | —FORWARD PHARMA A/S-ADR | 404,472 | $8.5B | 0.55% | |
| 46 | —PFENEX INC | 939,930 | $8.4B | 0.54% | |
| 47 | ABMDEURABIOMED INC | 63,290 | $8.1B | 0.53% | |
| 48 | —ABEONA THERAPEUTICS INC | 1,336,050 | $8.0B | 0.52% | |
| 49 | —AVEXIS INC | 190,000 | $7.8B | 0.51% | |
| 50 | —PSIVIDA CORP | 2,552,431 | $7.7B | 0.50% | |
| 51 | —ACHILLION PHARMACEUTICALS | 929,290 | $7.5B | 0.49% | |
| 52 | AKBAAKEBIA THERAPEUTICS INC | 809,096 | $7.3B | 0.47% | |
| 53 | —NEPTUNE TECHNOLOGIES AND BIORESOURCES | 6,750,444 | $7.2B | 0.46% | |
| 54 | —AGILE THERAPEUTICS INC | 1,020,011 | $7.1B | 0.46% | |
| 55 | AGENEURAGENUS INC | 900,000 | $6.5B | 0.42% | |
| 56 | —CAPITAL SENIOR LIVING CORP | 375,306 | $6.3B | 0.41% | |
| 57 | ARWRARROWHEAD PHARMACEUTICALS INC | 847,458 | $6.2B | 0.40% | |
| 58 | CLVSEURCLOVIS ONCOLOGY INC | 171,500 | $6.2B | 0.40% | |
| 59 | XENEXENON PHARMACEUTICALS INC | 762,800 | $6.2B | 0.40% | |
| 60 | SUPNSUPERNUS PHARMACEUTICALS INC | 244,550 | $6.0B | 0.39% | |
| 61 | —HISTOGENCIS CORP | 1,777,777 | $5.7B | 0.37% | |
| 62 | ASMBASSEMBLY BIOSCIENCES INC | 777,669 | $5.6B | 0.36% | |
| 63 | —CASCADIAN THERAPEUTICS INC | 3,414,121 | $5.6B | 0.36% | |
| 64 | —PROTEOSTASIS THERAPEUTICS INC | 344,550 | $5.4B | 0.35% | |
| 65 | ADMAADMA BIOLOGICS INC | 734,793 | $5.3B | 0.34% | |
| 66 | —ONCOBIOLOGICS INC | 1,248,990 | $5.3B | 0.34% | |
| 67 | AMRNAMARIN CORP PLC-ADR | 1,622,280 | $5.2B | 0.33% | |
| 68 | SELBUSDSELECTA BIOSCIENCES INC | 348,150 | $5.0B | 0.32% | |
| 69 | —NEURODERM LTD | 264,114 | $4.9B | 0.32% | |
| 70 | —ANTHERA PHARMACEUTICALS INC | 1,459,627 | $4.6B | 0.30% | |
| 71 | CLLSCELLECTIS ADR | 179,506 | $4.3B | 0.28% | |
| 72 | —CEMPRA INC | 175,503 | $4.2B | 0.27% | |
| 73 | —APPLIED GENETIC TECHNOLOGIES | 426,048 | $4.2B | 0.27% | |
| 74 | —ABEONA THERAPEUTICS INC-CW19 | 1,259,636 | $4.1B | 0.26% | |
| 75 | ONCBEIGENE LTD | 132,057 | $4.1B | 0.26% | |
| 76 | —MYLAN NV | 94,711 | $3.6B | 0.23% | |
| 77 | —INNOCOLL HOLDINGS PLC | 547,792 | $3.2B | 0.21% | |
| 78 | DVAXDYNAVAX TECHNOLOGIES CORP SHS PUT 12 12/16/2016 | 6,000 | $3.1B | 0.20% | Put |
| 79 | —AVEO PHARMACEUTICALS INC | 3,108,808 | $2.8B | 0.18% | |
| 80 | —APTEVO THERAPEUTICS INC | 988,133 | $2.5B | 0.16% | |
| 81 | —PROTEON THERAPEUTICS INC | 269,005 | $2.5B | 0.16% | |
| 82 | —OPHTHOTECH CORP CALL 80 12/16/2016 | 500,000 | $2.4B | 0.15% | Call |
| 83 | DVAXDYNAVAX TECHNOLOGIES CORP SHS PUT 10 12/16/2016 | 6,000 | $2.3B | 0.15% | Put |
| 84 | —MGC DIAGNOSTICS CORP | 329,733 | $2.3B | 0.15% | |
| 85 | —NEOS THERAPEUTICS INC | 330,593 | $2.2B | 0.14% | |
| 86 | —IGNYTA INC | 339,727 | $2.1B | 0.14% | |
| 87 | ACADACADIA PHARMACEUTICALS INC | 65,240 | $2.1B | 0.13% | |
| 88 | —AFFIMED NV | 734,301 | $2.0B | 0.13% | |
| 89 | —ARNO THERAPEUTICS INC | 4,177,577 | $2.0B | 0.13% | |
| 90 | ABTABBOTT LABORATORIES | 46,019 | $1.9B | 0.13% | |
| 91 | DVAXDYNAVAX TECHNOLOGIES CORP SHS PUT 11 12/16/2016 | 4,000 | $1.8B | 0.11% | Put |
| 92 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 129,920 | $1.7B | 0.11% | |
| 93 | —CHINA BIOLOGIC PRODUCTS INC | 13,695 | $1.7B | 0.11% | |
| 94 | BUWABIO RAD LABORATORIES CLASS A | 10,000 | $1.6B | 0.11% | |
| 95 | —MEDGENICS INC | 293,460 | $1.6B | 0.11% | |
| 96 | VCRAUSDVOCERA COMMUNICATIONS INC | 94,236 | $1.6B | 0.10% | |
| 97 | —ALLIQUA BIOMEDICAL INC | 1,921,951 | $1.5B | 0.10% | |
| 98 | VCELVERICEL CORP | 544,996 | $1.5B | 0.10% | |
| 99 | NVROEURNEVRO CORP | 11,746 | $1.2B | 0.08% | |
| 100 | —NIVALIS THERAPEUTICS INC | 122,275 | $994.0M | 0.06% |
Page 1 of 2Next